Efficacy of Apremilast on Quality-of-Life Measures in Patients with Moderate Plaque Psoriasis (UNVEIL Phase IV Study). (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s13. https://doi.org/10.25251/skin.1.supp.12